Related Experiment Video
Updated: Jul 3, 2026
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
[Effect of subchronic administered Bismerthlazol on thyroid glands of rats]
Jiong-Lin Zhou1, Pei-Yu Xu, Zheng-Shu Wang
1Department of Toxicology, West China School of Public Health, Sichuan University, Chengdu 610041, China.
Objective:
To test the impact of subchronically administered Bismerthlazol on the thyroid morphosis of rats.
Methods:
One hundred SD rats were randomly divided into one negative control group and four experimental groups with 7.0, 27.9, 111.7, and 447.0 mg/kg daily doses of Bismerthlazol, respectively. The Bismerthlazol was administered by gavage for 90 d. At the end of the experiment, the thyroids of the rats were harvested and weighted. The pathological changes of the thyroids were observed under light microscopes. The positive expression of PCNA in the thyroid glands were examined by histochemistry methods.
Results:
Increased coefficients of thyroid gland weight were found in the experimental groups (P < 0.01). The thyroid glands showed different hyperplasia of follicular cells. Increased positive cells of PCNA were observed in the experimental groups (P < 0.05 or P < 0.01) except for the 7.0 mg/kg dose group.
Conclusion:
Long-time administered Bismerthlazol causes thyroids hyperplasia in rats. Further study on the mechanisms is warranted.
Related Concept Videos
01:23Toxicity Testing in Animals
01:20Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...